May 12, 2016
Ono President Gyo Sagara Ono Pharmaceutical notched up record group sales in the year ended March 2016 thanks to the lung cancer indication added to Opdivo (nivolumab) and royalty revenues from Bristol-Myers Squibb for the immuno-oncology drug. In FY2015, Ono...read more